Wegovy® (Semaglutide Injection) – 0.25 mg | 0.5 mg | 1 mg | 1.7 mg | 2.4 mg

Wegovy® (Semaglutide Injection) is a prescription GLP-1 receptor agonist used for chronic weight management in adults with obesity or overweight conditions associated with metabolic risk factors. It works by regulating appetite, increasing satiety, and reducing overall calorie intake when combined with a reduced-calorie diet and physical activity.

Wegovy is administered as a once-weekly subcutaneous injection and is internationally recognized for its clinically proven weight-loss outcomes and long-term metabolic benefits. It is widely prescribed by healthcare professionals and trusted by patients worldwide.

Available strengths include 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg, allowing gradual dose escalation as per medical guidance.

Medicina Overseas supplies Wegovy® for international markets, supporting pharmacies, hospitals, clinics, and bulk importers with compliant sourcing and export-ready logistics.

⚠️ Prescription-only medicine. Use strictly under medical supervision.

✅ KEY BENEFITS (OPTIONAL – BOOSTS CONVERSION)

• Supports significant and sustained weight loss

• Once-weekly injection

• Clinically proven GLP-1 therapy

• Trusted brand by Novo Nordisk

• Used in obesity and metabolic health management